Targeting Fibronectin for Cancer Imaging and Therapy

Area of Science:

• Oncology
• Biochemistry
• Extracellular Matrix Biology

Background:

• Cancer progression involves significant changes in the extracellular matrix (ECM).
• Fibronectin (FN) is upregulated in the tumor ECM, aiding cancer cell migration, invasion, and growth.
• Elevated FN levels correlate with angiogenesis, metastasis, and drug resistance.

Purpose of the Study:

• To review the role of fibronectin in cancer.
• To discuss the development of fibronectin-targeting agents for cancer applications.
• To highlight the use of these agents in cancer imaging and therapy.

Main Methods:

• Literature review of studies on fibronectin in cancer.
• Analysis of fibronectin-targeting imaging and therapeutic agents.
• Summary of applications in cancer diagnosis, treatment, and image-guided interventions.

Main Results:

• Fibronectin is a key organizer of the tumor microenvironment, mediating crosstalk between cancer cells and their surroundings.
• Various FN-targeting agents, including those for nuclear imaging, MRI, fluorescence imaging, chemotherapy, and photothermal therapy, have been developed.
• These agents have demonstrated utility in tumor detection, localization, and therapeutic interventions.

Conclusions:

• Fibronectin overexpression in cancer presents a promising target for novel diagnostic and therapeutic strategies.
• FN-targeting agents hold potential for broad applications across multiple cancer types.
• Further development of these agents could significantly advance cancer care, including image-guided interventions.